Correction

Am Fam Physician. 2004 Nov 1;70(9):1648.

The Letter to the Editor, “Tolerance and Dependence Risk with the Use of Carisoprodol,” by Craig Heacock, M.D., and Mark S. Bauer, M.D. (April 1, 2004, page 1622), incorrectly stated that meprobamate is a schedule IV barbiturate with a long history of abuse. The second sentence in the first paragraph of the letter should have stated that meprobamate is a schedule IV drug that has a long history of abuse and exhibits cross-tolerance to barbiturates. Meprobamate is a bis-carbamate ester and is not a member of the barbiturate family. The online version of this letter has been corrected.


Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

Navigate this Article